Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of simenafil hydrochloride tablets in Alzheimer's disease
CTR20263955Phase 2Active
- Sponsor
- Vigonvita Life Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in Alzheimer's disease (AD), sponsored by Vigonvita Life Sciences. Started Oct 2026; status: active.
02
Drugs
sildenafil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20263955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263955.